“MUST READ”
Biocentury has a really good
interview with John Jenkins, who’s departing the FDA this week after 15 years
as director of the Office of New Drugs at the agency’s CDER (Center for Drug
Evaluation and Research). via Pocket
tags: IFTTT
Pocket
weeklylinks
Early on an unusually blustery
day in June, Kevin Esvelt climbed aboard a ferry at Woods Hole, bound for
Nantucket Island. via Pocket
TOOLS/TECHNIQUES
In both the U.S. and the EU,
transgenic genetically modified (GM) crops must be approved by regulatory
agencies before they can be marketed. Both the U.S. and EU have mandatory GM
labeling requirements, though the structures of the U.S. via Pocket
HEALTH/MEDECINE
Nearly 40 years since the
first ‘test-tube baby’, how close are we to editing out all of our genetic
imperfections – and should we even try to do so? Comfortably seated in the
fertility clinic with Vivaldi playing softly in the background, you and y…
COMPANIES
Illumina have announced
NovaSeq, an entirely new sequencing system that completely disrupts their
existing HiSeq user-base. In my opinion, if you have a HiSeq and you are
NOT currently engaged in planning to migrate to NovaSeq, then you will be out…
tags: IFTTT
Pocket
weeklylinks
Quiagen is entering the
promising field of multi-omics data analysis with the acquisition of a
bioinformatics company from the US. via Pocket
tags: IFTTT
Pocket
weeklylinks
Local genomics legend J. Craig
Venter is stepping aside from his post as chief executive officer of Human
Longevity Inc., turning over the helm to former GE Healthcare executive Cynthia
Collins. via Pocket
tags: IFTTT
Pocket
weeklylinks
Grail, a San Francisco startup
that aims to invent a blood test that can detect cancer early, announced this
afternoon that it plans to raise $1 billion in venture capital in its second
financing round, a sum that puts the biotech startup in a class…
SOMETHING
DIFFERENT
tags: smartphones
weeklylinks
- “What really matters?” in life. In her enlightening new book, “The Power of Off,” Nancy Colier observes that “we are spending far too much of our time doing things that don’t really matter to us.”
No comments:
Post a Comment